BR9709939A - Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado usos de éster tetraidro-3-furanila do ácido 3s[3r*(1r*,2s*)]-[-3-[[4-amino-fenil)sulfonil](2-metilprop ril)-amino]-2-hidroxi-1-fenilmetil)propil]-carbâmico de zidovudina e de (2r,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona e pacote para paciente - Google Patents
Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado usos de éster tetraidro-3-furanila do ácido 3s[3r*(1r*,2s*)]-[-3-[[4-amino-fenil)sulfonil](2-metilprop ril)-amino]-2-hidroxi-1-fenilmetil)propil]-carbâmico de zidovudina e de (2r,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona e pacote para pacienteInfo
- Publication number
- BR9709939A BR9709939A BR9709939A BR9709939A BR9709939A BR 9709939 A BR9709939 A BR 9709939A BR 9709939 A BR9709939 A BR 9709939A BR 9709939 A BR9709939 A BR 9709939A BR 9709939 A BR9709939 A BR 9709939A
- Authority
- BR
- Brazil
- Prior art keywords
- amino
- oxathiolan
- zidovudine
- carbamic
- phenylmethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2054396P | 1996-06-25 | 1996-06-25 | |
US2102796P | 1996-07-02 | 1996-07-02 | |
GBGB9614022.3A GB9614022D0 (en) | 1996-07-04 | 1996-07-04 | Antiviral therapeutic combinations |
PCT/EP1997/003247 WO1997049411A1 (en) | 1996-06-25 | 1997-06-23 | Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9709939A true BR9709939A (pt) | 1999-08-10 |
Family
ID=27268358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9709939A BR9709939A (pt) | 1996-06-25 | 1997-06-23 | Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado usos de éster tetraidro-3-furanila do ácido 3s[3r*(1r*,2s*)]-[-3-[[4-amino-fenil)sulfonil](2-metilprop ril)-amino]-2-hidroxi-1-fenilmetil)propil]-carbâmico de zidovudina e de (2r,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona e pacote para paciente |
Country Status (26)
Country | Link |
---|---|
US (1) | US6544961B1 (pt) |
EP (1) | EP0938321B1 (pt) |
JP (1) | JP2000515852A (pt) |
KR (1) | KR20000022226A (pt) |
CN (1) | CN1228026A (pt) |
AP (1) | AP9801419A0 (pt) |
AT (1) | ATE257708T1 (pt) |
AU (1) | AU727983B2 (pt) |
BR (1) | BR9709939A (pt) |
CA (1) | CA2258956A1 (pt) |
CO (1) | CO4900074A1 (pt) |
CZ (1) | CZ429498A3 (pt) |
DE (1) | DE69727240T2 (pt) |
EA (1) | EA001517B1 (pt) |
ES (1) | ES2213217T3 (pt) |
HU (1) | HUP9903249A3 (pt) |
ID (1) | ID19490A (pt) |
IL (1) | IL127351A0 (pt) |
IS (1) | IS4915A (pt) |
NO (1) | NO986034L (pt) |
NZ (1) | NZ333099A (pt) |
PL (1) | PL330747A1 (pt) |
TR (1) | TR199802704T2 (pt) |
TW (1) | TW469132B (pt) |
WO (1) | WO1997049411A1 (pt) |
YU (1) | YU58398A (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY115461A (en) | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
NZ554779A (en) * | 2005-02-01 | 2011-02-25 | Troikaa Pharmaceuticals Ltd | Injectable preparations of diclofenac ((2,6-dichloranilino)phenylacetic acid) and its pharmaceutically acceptable salts |
ES2279707B1 (es) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | Formulaciones orales que comprenden 3'-azidonucleosidos. |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
WO2009011861A1 (en) * | 2007-07-16 | 2009-01-22 | Poniard Pharmaceuticals, Inc. | Oral formulations for picoplatin |
US20110052580A1 (en) * | 2008-02-08 | 2011-03-03 | Poniard Pharmaceuticals, Inc. | Use of picoplatin and bevacizumab to treat colorectal cancer |
MX367937B (es) * | 2010-01-27 | 2019-09-12 | Viiv Healthcare Co | Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapéuticos. |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4724232A (en) * | 1985-03-16 | 1988-02-09 | Burroughs Wellcome Co. | Treatment of human viral infections |
US5047407A (en) | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
US5204466A (en) | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
IL100502A (en) | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2 - Hydroxymethyl - 5 -) 5 - Fluorocytocin - 1 - Eyal (- 1, 3 - Oxathiolane, its resolution and pharmaceuticals containing it |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
SK279262B6 (sk) | 1991-05-16 | 1998-08-05 | Glaxo Group Limited | Protivírusová zmes, farmaceutický prostriedok s je |
GB9111902D0 (en) | 1991-06-03 | 1991-07-24 | Glaxo Group Ltd | Chemical compounds |
GB9307013D0 (en) * | 1993-04-02 | 1993-05-26 | Wellcome Found | Therapeutic combinations |
DK0656887T3 (da) | 1992-08-25 | 1999-07-05 | Searle & Co | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser |
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
UA49803C2 (uk) * | 1994-06-03 | 2002-10-15 | Дж.Д. Сьорль Енд Ко | Спосіб лікування ретровірусних інфекцій |
GB9503850D0 (en) | 1995-02-25 | 1995-04-19 | Glaxo Group Ltd | Medicaments |
US5869461A (en) | 1995-03-16 | 1999-02-09 | Yale University | Reducing toxicity of L-nucleosides with D-nucleosides |
MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
US5646180A (en) * | 1995-12-05 | 1997-07-08 | Vertex Pharmaceuticals Incorporated | Treatment of the CNS effects of HIV |
TW536403B (en) | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
-
1997
- 1997-06-23 BR BR9709939A patent/BR9709939A/pt unknown
- 1997-06-23 NZ NZ333099A patent/NZ333099A/en unknown
- 1997-06-23 US US09/202,660 patent/US6544961B1/en not_active Expired - Fee Related
- 1997-06-23 ES ES97928263T patent/ES2213217T3/es not_active Expired - Lifetime
- 1997-06-23 CA CA002258956A patent/CA2258956A1/en not_active Abandoned
- 1997-06-23 EA EA199801045A patent/EA001517B1/ru not_active IP Right Cessation
- 1997-06-23 KR KR1019980710646A patent/KR20000022226A/ko not_active Application Discontinuation
- 1997-06-23 AU AU32627/97A patent/AU727983B2/en not_active Ceased
- 1997-06-23 CO CO97034781A patent/CO4900074A1/es unknown
- 1997-06-23 TR TR1998/02704T patent/TR199802704T2/xx unknown
- 1997-06-23 PL PL97330747A patent/PL330747A1/xx unknown
- 1997-06-23 EP EP97928263A patent/EP0938321B1/en not_active Expired - Lifetime
- 1997-06-23 JP JP10502320A patent/JP2000515852A/ja not_active Ceased
- 1997-06-23 WO PCT/EP1997/003247 patent/WO1997049411A1/en active Search and Examination
- 1997-06-23 HU HU9903249A patent/HUP9903249A3/hu unknown
- 1997-06-23 AP APAP/P/1998/001419A patent/AP9801419A0/en unknown
- 1997-06-23 ID IDP972147A patent/ID19490A/id unknown
- 1997-06-23 AT AT97928263T patent/ATE257708T1/de not_active IP Right Cessation
- 1997-06-23 DE DE69727240T patent/DE69727240T2/de not_active Expired - Fee Related
- 1997-06-23 CN CN97197357A patent/CN1228026A/zh active Pending
- 1997-06-23 IL IL12735197A patent/IL127351A0/xx unknown
- 1997-06-23 CZ CZ984294A patent/CZ429498A3/cs unknown
- 1997-08-05 TW TW086111193A patent/TW469132B/zh active
-
1998
- 1998-11-30 IS IS4915A patent/IS4915A/is unknown
- 1998-12-16 YU YU58398A patent/YU58398A/sr unknown
- 1998-12-22 NO NO986034A patent/NO986034L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP9903249A3 (en) | 2001-04-28 |
ES2213217T3 (es) | 2004-08-16 |
CA2258956A1 (en) | 1997-12-31 |
US6544961B1 (en) | 2003-04-08 |
ID19490A (id) | 1998-07-16 |
DE69727240T2 (de) | 2004-11-25 |
AU727983B2 (en) | 2001-01-04 |
KR20000022226A (ko) | 2000-04-25 |
CO4900074A1 (es) | 2000-03-27 |
ATE257708T1 (de) | 2004-01-15 |
EA001517B1 (ru) | 2001-04-23 |
NO986034D0 (no) | 1998-12-22 |
YU58398A (en) | 1999-11-22 |
WO1997049411A1 (en) | 1997-12-31 |
NZ333099A (en) | 2000-06-23 |
AP9801419A0 (en) | 1998-12-31 |
CZ429498A3 (cs) | 1999-06-16 |
EP0938321A1 (en) | 1999-09-01 |
NO986034L (no) | 1999-02-23 |
IS4915A (is) | 1998-11-30 |
AU3262797A (en) | 1998-01-14 |
JP2000515852A (ja) | 2000-11-28 |
TW469132B (en) | 2001-12-21 |
EP0938321B1 (en) | 2004-01-14 |
HUP9903249A2 (hu) | 2000-10-28 |
IL127351A0 (en) | 1999-10-28 |
TR199802704T2 (xx) | 1999-03-22 |
PL330747A1 (en) | 1999-05-24 |
CN1228026A (zh) | 1999-09-08 |
EA199801045A1 (ru) | 1999-08-26 |
DE69727240D1 (de) | 2004-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709939A (pt) | Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado usos de éster tetraidro-3-furanila do ácido 3s[3r*(1r*,2s*)]-[-3-[[4-amino-fenil)sulfonil](2-metilprop ril)-amino]-2-hidroxi-1-fenilmetil)propil]-carbâmico de zidovudina e de (2r,cis)-4-amino-1-(2-hidroximetil-1,3-oxatiolan-5-il)-(1h)-pirimidin-2-ona e pacote para paciente | |
AR036575A1 (es) | Eritropoyetina pegilada y diglicosilada | |
BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
BR9801355B1 (pt) | emulsço àleo-em-Água, composiÇço cosmÉtica de uso tàpico, utilizaÇço de uma emulsço, processo de tratamento nço terapÊutico da pele e processo de preparaÇço de uma emulsço. | |
RU94013464A (ru) | Нуклеозидные аналоги 1,3-оксатиолана, способ получения, фармацевтическая композиция, способ лечения вирусной инфекции | |
EA000626B3 (ru) | Синергические комбинации зидовудина, 1592u89 и зтс или ftc | |
AR029969A1 (es) | Aplicador para la aplicacion de un producto sobre fibras queratinicas, conjunto de aplicacion equipado con tal aplicador, y utilizacion de este conjunto | |
BRPI0108449B8 (pt) | formulações de pasta aperfeiçoada, suas aplicações farmacêuticas, método para matar insetos, bem como processo para preparar as referidas formulações | |
PT1152765E (pt) | Etanolato de azitromicina, processo de preparacao e composicoes farmaceuticas que os contem | |
BR0116084A (pt) | Amidas de ácido furanocarboxìlico e tiofenocarboxìlico ariladas com efeito bloqueador de canal de potássio | |
BR0014312B1 (pt) | composição farmacêutica contendo uma combinação farmacêutica compreendendo loteprednol e azelastina, medicamento e seu processo de produção, e uso da referida combinação. | |
PT97743A (pt) | Processo para a preparacao de composicoes farmaceuticas comportando baclofeno como ingrediente activo destinadas ao tratamento da angina de peito | |
ES2127490T3 (es) | Utilizacion de un aceite rico en acido petroselenico como agente hidratante. | |
BR0210374A (pt) | Amidas de ácido antranìlico com cadeia lateral de heteroarilsulfonila, processos para produção das mesmas, uso das mesmas como medicamento ou agente de diagnóstico, bem como preparações farmacêuticas que contêm as mesmas | |
BR9809117A (pt) | Composição de gel retardado de liberação prolongada, processo de produzir a mesma, formulação farmacêutica,e , processos de tratamento de uma indicação , de uma doença, e de uma inflamação com uma composição de liberação prolongada | |
HUP0004375A2 (hu) | Azelainsavat tartalmazó kompozíció | |
BR0311154A (pt) | Composição para melhorar o melasma e composição para reduzir a opacidade da pele | |
BR9814937A (pt) | Utilização de uma quantidade suficiente de pelo menos um extrato de pelo um vegetal do gênero chrysanthemum, composição cosmética ou farmacêutica e processo de tratamento cosmético. | |
BR0208367B1 (pt) | Composição farmacêutica para o tratamento de infecções oculares, para aplicação local, processo para a preparação de uma composição farmacêutica de colírio, adequada para aplicação local em oftalmologia, e, utilização de azitromicina | |
BR9404225A (pt) | Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações | |
BR9808060A (pt) | Composição farmacêutica, processos para tratamento de infecções virais pela administração de uma quantidade farmaceuticamente segura e eficaz de uma composição farmacêutica, uso da lamivudina ou um seu derivado farmaceuticamente aceitável, e, processo para a preparação de uma composição farmacêutica. | |
BR9706889A (pt) | Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba | |
BR9001484A (pt) | Composicao inseticida e acaricida com efeito aperfeicoado,processo para aperfeicoar o efeito de uma substancia ativa inseticida | |
BR9709951A (pt) | Combinação formulação farmacêutica processo de tratamento de uma infecção por hiv em um animal infectado uso de éster de tetraidro-3-furilanila do ácido 3s[3r*(1r,2s*)]-[3-[[4-amino-enil)sulfonil](2-metilpropil]-2-hiroxi-1-fenilmetil)propil]-carbânico, zidovudino,e (1s,4r)-cis-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il]-2-ciclopenteno-1-metanol e pacote para paciente | |
BR9807312B1 (pt) | Derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES. |